Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) ECT2 Antibodies:
anti-Human ECT2 Antibodies:
anti-Rat (Rattus) ECT2 Antibodies:
Go to our pre-filtered search.
Dog (Canine) Polyclonal ECT2 Primary Antibody for EIA, IP - ABIN401345
Tatsumoto, Xie, Blumenthal, Okamoto, Miki: Human ECT2 is an exchange factor for Rho GTPases, phosphorylated in G2/M phases, and involved in cytokinesis. in The Journal of cell biology 1999
Show all 7 references for ABIN401345
Human Polyclonal ECT2 Primary Antibody for EIA, WB - ABIN952020
Yun, Duan, Chen, Wu, Shen, Qian, Wang: Ischemic postconditioning modified renal oxidative stress and lipid peroxidation caused by ischemic reperfusion injury in rats. in Transplantation proceedings 2009
Show all 3 references for ABIN952020
Human Polyclonal ECT2 Primary Antibody for IF (p), IHC (p) - ABIN753853
Wang, Yan, Liu: Clinical significance of ECT2 expression in tissue and serum of gastric cancer patients. in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2016
Show all 2 references for ABIN753853
Human Polyclonal ECT2 Primary Antibody for IHC (p), WB - ABIN658589
Justilien, Fields: Ect2 links the PKCiota-Par6alpha complex to Rac1 activation and cellular transformation. in Oncogene 2009
Chicken Polyclonal ECT2 Primary Antibody for WB - ABIN2784903
Nagasaki, Kanada, Uyeda: A novel shRNA vector that enables rapid selection and identification of knockdown cells. in Plasmid 2007
These results suggest that Ect2 plays roles in multiple aspects of DNA damage response.
It was shown that the guanine exchange factors GEF-H1 (show ARHGEF2 Antibodies) and ECT2 must be downregulated for megakaryote polyploidization. The first (2N-4N) endomitotic cycle requires GEF-H1 (show ARHGEF2 Antibodies) downregulation, whereas subsequent cycles (>4N) require ECT2 downregulation.
Ect2 may play a role in neuronal differentiation and brain development in vivo.
results demonstrate the functional role of Ect2 in postnatal proliferating cells in the two lobes of the pituitary, thereby suggesting roles in developmental growth of the mammalian pituitary
indispensable role of the maturation-promoting factor ECT2 pathwy in polar body extrusion in mouse oocytes
ECT2 has a role in activating the Rho signaling pathways leading to malignant transformation
Data suggest that the expression of epithelial cell transforming sequence 2 oncogene (ECT2) can serve as an alternative measurement that can compensate for the inadequacy of the current carcinoembryonic antigen (CEA (show CEACAM5 Antibodies)) test in the diagnosis and monitoring of colorectal cancer patients.
Our data demonstrate that the cytokinetic proteins epithelial cell transforming 2 and Aurora kinase B (AurkB (show AURKB Antibodies)) are localized to stress granules in human astrocytoma cells
Kaplan-Meier analysis revealed that lower levels of Ect2 mRNA predicted higher overall survivals and biochemical recurrence (BCR (show BCR Antibodies))-free survivals in all patients or non-metastatic patients.
Our results suggest that ECT2 plays an important role during gastric cancer progression
Colorectal cancer patients with high expression levels of ECT2 had shorter overall survival.
ECT2 can crosstalk with RACGAP1 (show RACGAP1 Antibodies) to catalyse the GTP (show AK3 Antibodies) exchange involved in Rho signalling to further regulate tumour initiation and metastasis.
Up-regulation of ECT2 might contribute to the progression of gastric carcinogenesis and may be a useful prognostic indicator in gastric cancer.
Poly(ADP-ribosyl)ation is recognized by ECT2.
central spindle assembly and 2 Plk1 (show PLK1 Antibodies)-dependent phosphorylations are required to establish efficient binding of the Ect2 BRCT in early cytokinesis.
ECT2 expression is positively correlated with WHO pathologic grading and unfavorable survival, suggesting that ECT2 may be a potential therapeutic candidate in human gliomas.
The protein encoded by this gene is a guanine nucleotide exchange factor and transforming protein that is related to Rho-specific exchange factors and yeast cell cycle regulators. The expression of this gene is elevated with the onset of DNA synthesis and remains elevated during G2 and M phases. In situ hybridization analysis showed that expression is at a high level in cells undergoing mitosis in regenerating liver. Thus, this protein is expressed in a cell cycle-dependent manner during liver regeneration, and is thought to have an important role in the regulation of cytokinesis. Several transcript variants encoding two different isoforms have been found for this gene.
epithelial cell transforming sequence 2 oncogene
, protein ECT2-like
, epithelial cell-transforming sequence 2 oncogene
, protein ECT2
, epithelial cell transforming sequence 2 oncogene protein
, ect2 oncogene